MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 244 filers reported holding MYRIAD GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $747,000 | +111.6% | 25,703 | +234.8% | 0.40% | +157.1% |
| Q3 2018 | $353,000 | -61.0% | 7,676 | -68.3% | 0.15% | -46.3% |
| Q2 2018 | $906,000 | +158.1% | 24,231 | +32.6% | 0.29% | +100.7% |
| Q1 2017 | $351,000 | +23.2% | 18,268 | +6.8% | 0.14% | -4.7% |
| Q4 2016 | $285,000 | -27.3% | 17,100 | +33.6% | 0.15% | -21.1% |
| Q2 2016 | $392,000 | -46.3% | 12,800 | -34.4% | 0.19% | -61.1% |
| Q1 2016 | $730,000 | – | 19,500 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |